U.S. Preterm Infant Care Market
Advertisement
http://www.reportlinker.com/p0187242/US-Preterm-Infant-Care-Market.html
Report Description
Preterm infant care forms a significant part of the pediatric healthcare market in the U.S. as preterm births are one of the leading causes of infant mortality in the country. One in every eight births in the U.S. are preterm, and the condition is on an alarming rise due to factors such as induced fertility, labor treatments, poor prenatal care, inappropriate maternal age, obesity, and smoking. Preterm infant care products (equipment, drugs, and formulae) can thus be life-critical as they provide the respiratory, nutritional, and thermal support necessary for the survival of pre-term babies. The vital role of these products in preterm infant care thus forms the major factor driving market growth.
Advertisement
Market Estimates and Forecasts
In addition to market data on the submarkets of the U.S. preterm infant care market, each section of the report will identify and analyze the market trends, opportunities, and the factors driving or inhibiting market growth. The report will also draw a competitive landscape, in which it will profile the top 35 market players. The report categorizes the U.S. Preterm Infant Care market as follows:
(Diagnosis, therapy, and monitoring)
(For use in hospitals, after discharge, iron fortified cow's milk formulas, hydrolyzed whey based formulas, casein hydrolysate formulas, amino acid formulas)
(Antibiotics, bronchodilators, analgesics, diuretics, vassopressors, hematologic agents)
((Diagnosis, therapy, and monitoring)
What makes our reports unique?
- We provide the longest market segmentation chain in this industry- not many reports provide market breakdown up to level 5.
- We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
- We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
- Comprehensive market analysis for the following sectors:
Pharmaceuticals, Medical Devices, Biotechnology, Semiconductor and Electronics, Energy and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.
Key questions answered
- Which are the high-growth segments/cash cows and how is the market segmented in terms of devices, infant formula, drugs, services?
- What are market estimates and forecasts; which markets are doing well and which are not?
- Where are the gaps and opportunities; what is driving the market?
- Which are the key playing fields? Which are the winning edge imperatives?
- How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?
Powerful Research and analysis
The analysts working with MarketsandMarkets come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.
TABLE OF CONTENTS
1 INTRODUCTION
1.1 KEY TAKE AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKET ESTIMATES AND FORECASTS
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
2 SUMMARY
3 MARKET OVERVIEW
3.1 SOCIOECONOMIC IMPACT & COST ANALYSIS
3.2 DRIVERS
3.2.1 INCREASING INCIDENCE OF PRETERM BIRTHS
3.2.1.1 Inappropriate maternal age
3.2.1.2 Induced fertility treatments
3.2.1.3 Genetic predisposition
3.2.1.4 Lack of awareness and inadequate prenatal care
3.2.1.5 Obesity, diabetes, smoking
3.2.2 AVAILABILITY OF LOW-COST EQUIPMENT
3.2.3 GOVERNMENT INITIATIVES
3.3 RESTRAINTS & OPPORTUNITIES
3.3.1 HIGH ENTRY BARRIERS
3.3.2 NOVEL TRENDS IN INFANT FORMULAE
3.3.3 TECHNOLOGY DEVELOPMENTS
3.4 NOVEL APPROACHES TO PRETERM INFANT CARE
3.4.1 DEVELOPMENTAL CARE
3.4.2 NEONATAL INFORMATION SYSTEMS
3.5 KEY FINDINGS
4 PRETERM INFANT CARE SERVICES MARKET
4.1 OVERVIEW
4.2 THERAPY & MONITORING SERVICES
4.3 DIAGNOSIS
5 U.S. PRETERM INFANT CARE, PRODUCTS MARKET
5.1 OVERVIEW
5.2 DELIVERY SYSTEMS
5.2.1 DRIVERS
5.2.1.1 Integral part of preterm babies treatment
5.2.1.2 Replacement units & price differentiation generating revenues
5.2.2 RESTRAINTS
5.2.2.1 Lack of technology differentiation
5.2.2.2 Low priced devices
5.2.3 OPPORTUNITY
5.2.3.1 Systems addressing pain management
5.2.4 FEEDING TUBES
5.2.5 INTRAVENOUS LINES
5.2.6 UMBILICAL CATHETER
5.2.7 PERIPHERALLY INSERTED CENTRAL CATHETER LINE
5.3 BILI LIGHTS
5.4 RESPIRATORY ASSISTANCE DEVICES
5.4.1 DRIVERS
5.4.1.1 Life saving devices
5.4.1.2 Large number of babies suffering from respiratory distress syndrome
5.4.1.3 Changing technologies
5.4.2 RESTRAINTS
5.4.2.1 Life threatening harmful effects of some devices
5.4.2.2 Low cost ventilators
5.4.2.3 Opportunities
5.4.2.3.1 Software solutions make the device user friendly
5.4.2.3.2 Home care devices
5.5 THERMAL CONTROL EQUIPMENTS
5.5.1 DRIVERS
5.5.1.1 Life saving portable and versatile equipment
5.5.1.2 Portable and versatile systems
5.5.2 RESTRAINT
5.5.2.1 Low cost
5.5.3 OPPORTUNITY
5.5.3.1 Scope for structural improvements
5.6 MONITORING DEVICES
5.6.1 DRIVERS
5.6.1.1 Novel IT solutions
5.6.1.2 Non invasive techniques & point-of-care analyzers
5.6.1.2.1 Increasing demand for reliable patient data
5.6.1.2.2 Necessity of the devices in early detection of abnormality
5.6.2 RESTRAINTS
5.6.2.1 Cost reductions
5.6.3 OPPORTUNITY
5.6.3.1 Expanded use of microprocessing technology
5.6.3.2 Lab-on-chip monitoring devices
5.6.3.3 Nanobarcodes and RFID
5.7 DIAGNOSTIC EQUIPMENT
5.7.1 DRIVERS
5.7.1.1 Technology advances enhancing consumption
5.7.2 RESTRAINTS
5.7.2.1 Requires high investments
5.7.2.2 Inadequate clinical trials of the devices
5.7.3 OPPORTUNITY
5.7.3.1 Nano enabled devices & integration of nanotech and IT
5.7.4 IMAGING EQUIPMENT
5.8 PRE TERM INFANT FORMULA
5.9 CHANGING TRENDS IN THE PRETERM INFANT FORMULA INDUSTRY
5.10 PRETERM FORMULAS FOR USE IN HOSPITALS
5.11 PRETERM FOLLOW-UP FORMULAS AFTER DISCHARGE
5.12 DRUGS
6 COMPETITIVE LANDSCAPE
6.1 OVERVIEW
7 GEOGRAPHIC ANALYSIS
7.1 OVERVIEW
7.2 OPPORTUNITIES
7.3 MISSISSIPPI
7.3.1 QUICK FACTS
7.3.2 RISK FACTOR ANALYSIS
7.4 ALABAMA
7.4.1 QUICK FACTS
7.4.2 RISK FACTOR ANALYSIS
7.5 DISTRICT OF COLUMBIA
7.5.1 QUICK FACTS
7.5.2 RISK FACTOR ANALYSIS
7.6 LOUISIANA
7.6.1 QUICK FACTS
7.6.2 RISK FACTOR ANALYSIS
7.7 KENTUCKY
7.7.1 QUICK FACTS
7.7.2 RISK FACTOR ANALYSIS
7.8 SOUTH CAROLINA
7.8.1 RISK FACTOR ANALYSIS
7.9 TENNESSEE
7.9.1 RISK FACTOR ANALYSIS
7.10 NEVADA
7.10.1 RISK FACTOR ANALYSIS
7.11 NEW MEXICO
7.11.1 RISK FACTOR ANALYSIS
7.12 GEORGIA
7.12.1 RISK FACTOR ANALYSIS
7.13 WEST VIRGINIA
7.13.1 RISK FACTOR ANALYSIS
7.14 OKLAHOMA
7.14.1 RISK FACTOR ANALYSIS
7.15 FLORIDA
7.15.1 RISK FACTOR ANALYSIS
7.16 TEXAS
7.16.1 RISK FACTOR ANALYSIS
7.17 ARKANSAS
7.17.1 RISK FACTOR ANALYSIS
7.18 CALIFORNIA
7.18.1 RISK FACTOR ANALYSIS
7.19 NEW YORK
7.19.1 RISK FACTOR ANALYSIS
7.20 OHIO
7.20.1 RISK FACTOR ANALYSIS
7.21 ILLINOIS
7.21.1 RISK FACTOR ANALYSIS
7.22 PENNSYLVANIA
7.22.1 RISK FACTOR ANALYSIS
8 PATENT ANALYSIS
8.1 PATENT ANALYSIS BY ASSIGNEE
8.2 PATENT ANALYSIS BY PRODUCTS
8.3 PATENT ANALYSIS BY EQUIPMENT
9 COMPANY PROFILES
9.1 ABBOTT NUTRITION
9.2 ANALOGIC CORP
9.3 ATOM MEDICAL INTERNATIONAL CORP.
9.4 ARJOHUNTLEIGH
9.5 CAREFUSION INC
9.6 CAS MEDICAL SYSTEMS INC
9.7 CHILDREN'S HOSPITAL OF PHILADELPHIA
9.8 CHILDREN'S NATIONAL MEDICAL CENTER
9.9 CLINICAL INNOVATIONS
9.10 COVIDIEN LTD.
9.11 CRITICARE SYSTEMS, INC.
9.12 DRAEGERWERK AG & CO. KGAA
9.13 EDAN INSTRUMENTS, INC
9.14 FISHER & PAYKEL HEALTHCARE CORP.
9.15 FUKUDA DENSHI CO. LTD.
9.16 GE HEALTHCARE
9.17 HAMILTON MEDICAL AG
9.18 KCBIOMEDIX, INC
9.19 MASIMO CORP.
9.20 MEAD JOHNSON NUTRITION CO
9.21 MEDELA INC.
9.22 MEDIX I.C.S.A
9.23 NATUS MEDICAL INC.
9.24 NESTLE NUTRITION
9.25 NEWYORK-PRESBYTERIAN MORGAN STANLEY CHILDREN'S HOSPITAL
9.26 NIHON KOHDEN CORP.
9.27 NONIN MEDICAL INC.
9.28 ORIDION SYSTEMS LTD
9.29 PEDIATRIX MEDICAL GROUP
9.30 PHOENIX MEDICAL SYSTEMS PVT LTD
9.31 PHILIPS RESPIRONICS INC
9.32 SPACELABS MEDICAL, INC
9.33 UTAH MEDICAL PRODUCTS, INC.
9.34 WELCH ALLYN INC.
9.35 WYETH NUTRITION CORP
APPENDIX
PATENTS
LIST OF TABLES
SUMMARY TABLE U.S. PRETERM INFANT CARE MARKET 2007 - 2014 ($MILLIONS)
TABLE 1 U.S. PRETERM INFANT CARE MARKET, BY SEGMENT 2007 - 2014 ($MILLIONS)
TABLE 2 U.S. PRETERM INFANT CARE SERVICES MARKET, 2007 - 2014 ($MILLIONS)
TABLE 3 U.S. PRETERM INFANT CARE EQUIPMENT MARKET, BY PRODUCTS 2007 - 2014 ($MILLIONS)
TABLE 4 U.S. PRETERM INFANT CARE THERAPY & MONITORING EQUIPMENT MARKET, 2007 - 2014 ($MILLIONS)
TABLE 5 PREMATURE DIAGNOSTIC DEVICES
TABLE 6 THERMAL CONTROL DEVICES
TABLE 7 MONITORING DEVICES
TABLE 8 DIAGNOSTIC EQUIPMENT
TABLE 9 U.S. PRETERM INFANT FORMULA MARKET, BY PRODUCTS 2007 - 2014 ($MILLIONS)
TABLE 10 AGREEMENTS AND COLLABORATIONS IN THE PRETERM INFANT CARE MARKET (2007-2009)
TABLE 11 NEW PRODUCT LAUNCHES IN THE PRETERM INFANT CARE MARKET (2007-2009)
TABLE 12 MERGERS AND ACQUISITIONS IN THE PRETERM INFANT CARE MARKET (2006-2009)
TABLE 13 PRETERM BIRTH RATE IN ETHNICITIES - MISSISSIPPI
TABLE 14 PRETERM BIRTH RATE IN ETHNICITIES - ALABAMA
TABLE 15 PRETERM BIRTH RATE IN ETHNICITIES - DISTRICT OF COLUMBIA
TABLE 16 PRETERM BIRTH RATE IN ETHNICITIES - LOUISIANA
TABLE 17 PRETERM BIRTH RATE IN ETHNICITIES - KENTUCKY
TABLE 18 PRETERM BIRTH RATE IN ETHNICITIES - SOUTH CAROLINA
TABLE 19 PRETERM BIRTH RATE IN ETHNICITIES - TENNESSEE
TABLE 20 PRETERM BIRTH RATE IN ETHNICITIES - NEVADA
TABLE 21 PRETERM BIRTH RATE IN ETHNICITIES - NEW MEXICO
TABLE 22 PRETERM BIRTH RATE IN ETHNICITIES - GEORGIA
TABLE 23 PRETERM BIRTH RATE IN ETHNICITIES - WEST VIRGINIA
TABLE 24 PRETERM BIRTH RATE IN ETHNICITIES - OKLAHOMA
TABLE 25 PRETERM BIRTH RATE IN ETHNICITIES - FLORIDA
TABLE 26 PRETERM BIRTH RATE IN ETHNICITIES - TEXAS
TABLE 27 PRETERM BIRTH RATE IN ETHNICITIES - ARKANSAS
TABLE 28 PRETERM BIRTH RATE IN ETHNICITIES - CALIFORNIA
TABLE 29 PRETERM BIRTH RATE IN ETHNICITIES - NEW YORK
TABLE 30 PRETERM BIRTH RATE IN ETHNICITIES - OHIO
TABLE 31 PRETERM BIRTH RATE IN ETHNICITIES - ILLINOIS
TABLE 32 PRETERM BIRTH RATE IN ETHNICITIES - PENNSYLVANIA
LIST OF FIGURES
FIGURE 1 CURRENT PRETERM BIRTH RATE IN THE U.S.
FIGURE 2 SOCIOECONOMIC COSTS
FIGURE 3 INCREASING RATES PRETERM BIRTHS IN THE U.S.
FIGURE 4 PROMINENT RISK FACTORS CAUSING PRETERM BIRTHS
FIGURE 5 DEVELOPMENTAL CARE
FIGURE 6 UTILIZATION RATES OF RESPIRATORY ASSISTANCE DEVICES IN PRETERM INFANT CARE
FIGURE 7 TECHNOLOGY TRENDS IN THE RESPIRATORY ASSISTANCE DEVICES MARKET
FIGURE 8 PERCENT UTILIZATION RATES OF THERMAL CONTROL EQUIPMENT
FIGURE 9 TECHNOLOGY TRENDS IN THE MONITORING DEVICES MARKET
FIGURE 10 TECHNOLOGY DEVELOPMENT IN THE DIAGNOSTIC EQUIPMENT MARKET
FIGURE 11 UTILIZATION RATES OF DIAGNOSTIC EQUIPMENT IN PRETERM INFANT CARE
FIGURE 12 PRODUCT DEVELOPMENT IN THEPRETERM INFANT CARE MARKET
FIGURE 13 PRODUCT DEVELOPMENTS IN MEDICAL DEVICES
FIGURE 14 NEW PRODUCT LAUNCHES
FIGURE 15 AGREEMENTS AND COLLABORATIONS
FIGURE 16 PRETERM BIRTH RATES, BY STATES
FIGURE 17 PATENT ANALYSIS, BY ASSIGNEE (2000 - 2009)
FIGURE 18 PATENTS ANALYSIS, BY PRODUCTS (2000 - 2009)
FIGURE 19 PATENTS ANALYSIS, BY EQUIPMENT (2000 - 2009)
FIGURE 20 PATENT ANALYSIS, BY THERAPY & MONITORING EQUIPMENT (2000 - 2009)
To order this report:
Caring Services Industry: U.S. Preterm Infant Care Market
More Market Research Report
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
-- Preterm Infant Care Equipment
SOURCE Reportlinker
